Diabetic macroangiopathy
Conditions
Interventions
Group 1:Shenqi compound addition and subtraction
Group 2:Metformin tablets
Sponsors
Affiliated Hospital of Chengdu University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
35 Years to 65 Years
Inclusion criteria
Inclusion criteria: (1) Voluntary participation and signing of informed consent; (2) Aged 35 to 65 years old; (3) Those who meet the newly diagnosed type 2 diabetes and TCM spleen deficiency syndrome; (4) Glycated hemoglobin = 7.5%.
Exclusion criteria
Exclusion criteria: (1) With severe liver and kidney and blood system diseases; (2) Acute complications of diabetes and mental illness have occurred in the past month; (3) Pregnancy or lactation; (4) Those who have been seriously infected within 1 month; (5) In addition to metformin, other hypoglycemic agents are used or high-dose aspirin (over 300 mg/day), anti-platelet aggregation, fibrates, thiazolidinediones, and statins are used; (6) Those with high sensitivity; (7) Those who do not cooperate during the introduction period; (8) Those who have a history of drug abuse or alcohol abuse.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| blood sugar;Glycated hemoglobin;Super Oxide Dimutase;Reactive oxygen species;Nitiogen monoxide;Malondialdehyde;Total-antioxidant capacity; | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood lipid; | — |
Countries
China
Contacts
Public ContactHongyan Xie
Chengdu University of Traditional Chinese Medicine Clinical Medical College
Outcome results
None listed